You are here

580b57fcd9996e24bc43c53e   LinkedIn Logo 500x500   Facebook logo square   Iguana Trans cropped

event icon
Start time
End time
Online (Zoom)

An online Policy Lates panel discussion exploring how addressing inequity in clinical research design can benefit public health and wellbeing.

This event will take place from 18:30 BST, finishing at 20:00.

The importance of good clinical trials has been particularly visible to the public with the emergence of COVID-19 and the work undertaken to research and develop vaccines and therapeutics. Devastatingly, the pandemic has also laid bare the inequalities in health outcomes among different communities in our society. Although vaccines and therapeutics are generally intended for use across society, the diversity of trial participant groups in clinical and population level studies does not always reflect society well. This lack of appropriate representation can lead to differences in real-world health benefits and outcomes arising from the application of clinical trials results. Equitable research design should ensure that therapeutic benefit can be more accurately predicted for likely treatment groups. There is work to be done across many stages of the research and development process, to reach a fully equitable system of access, engagement in, and benefit from, clinical research. To better understand and tackle inequalities of the research system, we must address participant diversity in clinical research, and how barriers to this can be overcome.

This event will focus on clinical trials and population studies. We will explore how addressing inequity in clinical research design can benefit public health and wellbeing. An expert panel will cover innovative initiatives, research funding incentives and policies that support equitable research design. We aim to highlight some thinking, information and contacts relevant to clinical health researchers, policymakers (especially those working in research institutes and for research funders) and others who utilise clinical trials results, to support actions promoting health equality across communities in our society, through improvements in this specific area of research design.

This event will be chaired by Professor Winston Morgan FRSB, director of impact & innovation, School of Health Sport and Bioscience, University of East London. Further panellists will be confirmed in due course, and all information will be available on this page.

Policy Lates format

All are welcome to attend this online edition of our Policy Lates series, which provides an opportunity for relaxed discussion with an interested and informed audience. This online event will begin with an introduction from the chair, followed by short talks from our panellists, with time for audience questions and panel discussion.


This event is free to attend and open to all. Advance booking is essential via the link at the top of the page, and the Zoom link will be circulated to all registered attendees ahead of the event.

Social media

If you would like to share your experience of this event on social media, feel free to tag us @RoyalSocBio on Twitter and Instagram, and use the hashtag #RSBPolicyLates


This online event will be recorded, and screenshots may be taken. If you have any queries about this, please contact us at ahead of the event. This event will be in a webinar format, and you will be unable to turn on your camera and microphone for the duration of the meeting. Audience questions will be through from the Zoom Q&A function.

Continuing Professional Development

This event is approved by the Royal Society of Biology for purposes of CPD and can be counted as 6 CPD points.


For all enquiries, please contact Harriet McAra or on 020 3925 3445.